Evidence map›Paper›PMID 27762303›Full record

ArticleScientific reports2016

AKT/GSK3β signaling pathway is critically involved in human pluripotent stem cell survival.

Leonardo Romorini, Ximena Garate, Gabriel Neiman, Carlos Luzzani, Verónica Alejandra Furmento, Alejandra Sonia Guberman, Gustavo Emilio Sevlever, María Elida Scassa, Santiago Gabriel Miriuka

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 1 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 1 synthesis or guideline pooled it, 103 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. [Quercetin, a key bioactive component of Zuogui Pill, protects against AlzheimerZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2026
    Article
  4. Article
  5. Review
  6. Dual-action peptide KWHVeterinary research · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Differential Roles of Neuro-Inflammatory Regulator, MAPK11 in Cortex and Hippocampus Following Post-Stroke Cognitive Impairments in Rats.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Leonardo RomoriniLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Ximena GarateLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Gabriel NeimanLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Carlos LuzzaniLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Verónica Alejandra FurmentoLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Alejandra Sonia GubermanLaboratorio de Regulación de Expresión Génica, IQUIBICEN, UBA/CONICET, Dptos. de Química Biológica y de Fisiología, Biología Molecular y Celular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Intendente Güiraldes 2160, Buenos Aires, C1428EGA, Argentina.
Gustavo Emilio SevleverLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
María Elida ScassaLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Santiago Gabriel MiriukaLaboratorios de Investigación Aplicada en Neurociencias (LIAN-CONICET), Fundación FLENI, Ruta 9, Km 52.5, Escobar, Buenos Aires, B1625XAF, Argentina.
Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia · ARConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human embryonic and induced pluripotent stem cells are self-renewing pluripotent stem cells (PSC) that can differentiate into a wide range of specialized cells. Basic fibroblast growth factor is essential for PSC survival, stemness and self-renewal. PI3K/AKT pathway regulates cell viability and apoptosis in many cell types. Although it has been demonstrated that PI3K/AKT activation by bFGF is relevant for PSC stemness maintenance its role on PSC survival remains elusive. In this study we explored the molecular mechanisms involved in the regulation of PSC survival by AKT. We found that inhibition of AKT with three non-structurally related inhibitors (GSK690693, AKT inhibitor VIII and AKT inhibitor IV) decreased cell viability and induced apoptosis. We observed a rapid increase in phosphatidylserine translocation and in the extent of DNA fragmentation after inhibitors addition. Moreover, abrogation of AKT activity led to Caspase-9, Caspase-3, and PARP cleavage. Importantly, we demonstrated by pharmacological inhibition and siRNA knockdown that GSK3β signaling is responsible, at least in part, of the apoptosis triggered by AKT inhibition. Moreover, GSK3β inhibition decreases basal apoptosis rate and promotes PSC proliferation. In conclusion, we demonstrated that AKT activation prevents apoptosis, partly through inhibition of GSK3β, and thus results relevant for PSC survival.

Indexed as

Signal TransductionCells, CulturedCell SurvivalGene Expression RegulationGlycogen Synthase Kinase 3 betaHumansOncogene Protein v-aktPluripotent Stem CellsGlycogen Synthase Kinase 3 betaOncogene Protein v-akt

Identifiers

PMID27762303
PMCPMC5071844
OpenAlexW2533006316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.